An Empirical Study on Generic Medicine and Branded Medicine

Author:

Amit R. Jaiswal 1,Kuldip Dadarao Belurkar 1

Affiliation:

1. P. R. Pote Patil College of Pharmacy, Amravati, Maharashtra, India

Abstract

In a person's mind, there are certain myths and misconceptions regarding generic medicines and their uses, safety, and potency, due to the information prevailing in the community. But the actual facts are totally different from that, and this is based on scientific evidence. The purpose of this review is to create awareness and increase knowledge about generic medicine as well as prescribe generic medicine in India. Generic medicine is the same as branded medicine, and it has the same quality, safety, and efficiency as branded medicine. Both medicines undergo rigorous regulatory testing, and after compliance with regulatory requirements, they get approval for marketing. Generic medicines are less costly as compared to branded ones because they do not undergo drug discovery, preclinical studies, advertisements, and so on. Due to this reduction in all processes, billions of dollars are saved, and manufacturing costs are low. Instead, all processes for generic medicine Bioequivalence and bioavailability studies prove that medicines are safe, effective, and as similar as branded products in terms of therapeutic effects and any side effects. To increase generic prescribing and acceptance in India, healthcare professionals have created an awareness program, given knowledge, and promoted generic prescriptions. The prescribing of drugs by a registered medical practitioner with the best utilization of practice and experience according to the disease condition of patients

Publisher

Naksh Solutions

Reference36 articles.

1. Kuchekar BS. Pharmaceutical jurisprudence. Pragati Books Pvt. Ltd.; 2008 Jan 8.Gundersen L. The complex process of naming drugs.

2. Pasupula SK, Sanjay Y, Raviteja C. Attitude towards generic drugs: A comparative Study among clinicians and pharmacy professionals. Telangana Journal of Psychiatry. 2018 Jul 1;4(2):72.

3. Mogolian, E., & Mrydral, P. (2004). What’s the difference between brand-name and Generic prescription drugs. Sci Am, 12-13.

4. Lipsky MS, Sharp LK. From idea to market: the drug approval process. The Journal of The American Board of Family Practice. 2001 Sep 1;14(5):362-7.

5. Lipsky MS, Sharp LK. From idea to market: the drug approval process. The Journal of The American Board of Family Practice. 2001 Sep 1;14(5):362-7

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3